PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-11.93%
Negative revenue growth while WEED.TO stands at 10.92%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-15.04%
Negative gross profit growth while WEED.TO is at 71.07%. Joel Greenblatt would examine cost competitiveness or demand decline.
-960.92%
Negative EBIT growth while WEED.TO is at 84.69%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-1383.16%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-825.75%
Negative net income growth while WEED.TO stands at 81.19%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-782.35%
Negative EPS growth while WEED.TO is at 84.62%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-500.00%
Negative diluted EPS growth while WEED.TO is at 84.62%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
5.01%
Share reduction more than 1.5x WEED.TO's 21.85%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
5.01%
Diluted share reduction more than 1.5x WEED.TO's 21.85%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
85.85%
OCF growth 1.25-1.5x WEED.TO's 68.82%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
50.46%
FCF growth 50-75% of WEED.TO's 67.42%. Martin Whitman would see if structural disadvantages exist in generating free cash.
21610.35%
10Y revenue/share CAGR above 1.5x WEED.TO's 1039.49%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-58.90%
Negative 5Y CAGR while WEED.TO stands at 25.46%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-34.59%
Negative 3Y CAGR while WEED.TO stands at 43.99%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
83.84%
10Y OCF/share CAGR above 1.5x WEED.TO's 15.32%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
96.51%
5Y OCF/share CAGR 1.25-1.5x WEED.TO's 83.25%. Bruce Berkowitz would see if capital spending or working-capital efficiencies explain the difference.
93.36%
3Y OCF/share CAGR 1.25-1.5x WEED.TO's 84.45%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-1432.24%
Both face negative decade-long net income/share CAGR. Martin Whitman would suspect a shrinking or highly disrupted sector.
-4510.94%
Negative 5Y net income/share CAGR while WEED.TO is 26.50%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-1077.29%
Negative 3Y CAGR while WEED.TO is 95.79%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
1098.12%
10Y equity/share CAGR above 1.5x WEED.TO's 207.79%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
-52.70%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
-68.46%
Both show negative short-term equity/share CAGR. Martin Whitman suspects an industry slump or unprofitable expansions for both players.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-8.31%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-0.98%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-18.81%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
-25.50%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
-7.99%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
41.67%
R&D growth of 41.67% while WEED.TO is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
-14.49%
We cut SG&A while WEED.TO invests at 245.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.